MKI67 and gonorrhea: Interestingly, while the PAC + miR-708-5p treatment decreased Ki-67 positivity, this treatment had a significantly higher Ki-67+ population compared to PAC and PAC + NC miR treated samples (Figure 6B, p < 0.05, n ≥ 3).